Cover Image

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [electronic resource]

Saved in:
Bibliographic Details
Online Access: Online Access
Corporate Authors: United States. Agency for Health Care Policy and Research, Blue Cross and Blue Shield Association. Technology Evaluation Center
Format: Government Document Electronic eBook
Language:English
Published: [Rockville, Md.] : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], [1999]
Series:AHCPR pub. ; no. 99-E 011.
Evidence report/technology assessment. Summary ; no. 4.
Subjects:
Prostate > Cancer > Hormone therapy.
Antiandrogens > Therapeutic use.
Androgen Antagonists > therapeutic use.
Cost-Benefit Analysis.
Gonadotropin-Releasing Hormone > antagonists & inhibitors.
Outcome Assessment, Health Care.
Prostatic Neoplasms > drug therapy.
Randomized Controlled Trials as Topic.

Internet

Online Access

Online

Holdings details from Online
Call Number: HE 20.6524:4/SUM
HE 20.6524:4/SUM Available

Similar Items